MM
ABBV icon

Meridian Management’s AbbVie ABBV Stock Holding History

Meridian Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,353
Closed -$240K – 72
2024
Q4 		$240K Buy
1,353
+25
+2% +$4.6K 0.06% 88
2024
Q3 		$262K Buy
1,328
+74
+6% +$13.8K 0.07% 84
2024
Q2 		$215K Buy
1,254
+1
+0.1% +$166 0.06% 90
2024
Q1 		$228K Buy
1,253
+6
+0.5% +$1.03K 0.06% 91
2023
Q4 		$217K Buy
+1,247
New +$182K 0.06% 90

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Meridian Management's ABBV Position: Q1 2025 in Review

Meridian Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,353 shares — an estimated $240K sold.

Meridian Management first reported a position in ABBV in Q4 2023 and held it in 5 quarters. The position peaked at $262K in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Meridian Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Meridian Management sold 1,353 AbbVie shares in Q1 2025, an estimated $240K.
  • Meridian Management first reported a position in AbbVie in Q4 2023 and held it in 5 quarters.
  • Meridian Management's AbbVie position peaked at $262K in Q3 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Meridian Management's 13F filing for Q1 2025, filed 7 May 2025.